Literature DB >> 14514444

Dose-response studies on the induction of liver cytochromes P4501A1 and 1B1 by polycyclic aromatic hydrocarbons in arylhydrocarbon-responsive C57BL/6J mice.

T Shimada1, A Sugie, T Yamada, H Kawazoe, M Hashimoto, E Azuma, T Nakajima, K Inoue, Y Oda.   

Abstract

1. To determine the biological effects of 23 polycyclic aromatic hydrocarbons (PAHs) and 3,4,3',4'-tetrachlorobiphenyl, the dose-response studies of the induction of CYP1-dependent xenobiotic oxidation activities by these chemicals in liver microsomes of C57BL/6J mice were studied. 2. In arylhydrocarbon-responsive C57BL/6J mice, the liver microsomal xenobiotic oxidation with substrates of 7-ethoxyresorufin, 7-ethoxycoumarin, (+/-)-benzo[a]pyrene-7,8-diol, dibenzo[a, pyrene-11,12-diol and 2-amino-3,5-dimethylimidazo[4,5-f]quinoline increased by increasing the doses of PAHs to mice, particularly when the PAHs that have been reported to be carcinogenic in experimental animals were used. In arylhydrocarbon receptor-knockout mice, there were no increases in liver microsomal 7-ethoxyresorufin O-deethylation activities nor in liver mRNA levels of CYP1A1, 1A2 and 1B1 by these chemicals. 3. Of the chemicals examined, benzo[k]fluoranthene, benzo[b]fluoranthene, benzo[j]-fluoranthene, 3-methylcholanthrene, dibenz[a,h]anthracene, dibenz[a,c]anthracene and 3,4,3',4'-tetrachlorobiphenyl were potent inducers of the induction of liver microsomal 7-ethoxyresorufin O-deethylation in mice. 4. Other PAHs such as 5-methylchrysene, benzo[a]pyrene, dibenzo[a,l]pyrene, dibenz[a,j]acridine, benzo[a]anthracene and 7,12-dimethylbenz[a]anthracene moderately induced 7-ethoxyresorufin O-deethylation activities in mice. PAHs reported to be weak or less carcinogenic in experimental animals did not induce the xenobiotic oxidation activities of CYP1A1 and 1B1 in the mice. 5. The results suggest that induction of liver microsomal CYP1-dependent xenobiotic oxidation activities is a good tool in determining the potencies of carcinogenic PAHs in arylhydrocarbon-responsive C57BL/6J mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14514444     DOI: 10.1080/0049825031000140896

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  6 in total

1.  Benzo[ a]pyrene Induction of Glutathione S-Transferases: An Activity-Based Protein Profiling Investigation.

Authors:  Ethan G Stoddard; Bryan J Killinger; Subhasree A Nag; Jude Martin; Richard Corley; Jordan N Smith; Aaron T Wright
Journal:  Chem Res Toxicol       Date:  2019-04-12       Impact factor: 3.739

2.  Reduced cytochrome P4501A activity and recovery from oxidative stress during subchronic benzo[a]pyrene and benzo[e]pyrene treatment of rainbow trout.

Authors:  Lawrence R Curtis; Claudia B Garzon; Mary Arkoosh; Tracy Collier; Mark S Myers; Jon Buzitis; Mark E Hahn
Journal:  Toxicol Appl Pharmacol       Date:  2011-04-29       Impact factor: 4.219

3.  Benzo[a]pyrene increases the Nrf2 content by downregulating the Keap1 message.

Authors:  Phuong Minh Nguyen; Miki Susanto Park; Marilynn Chow; Jae H Chang; Lisa Wrischnik; William K Chan
Journal:  Toxicol Sci       Date:  2010-05-23       Impact factor: 4.849

4.  Effects of pristane on cytochrome P450 isozyme expression in rat tissues.

Authors:  Carolyn B Howard; Jacqueline Samuel; Shalonda B Henderson; Jacqueline Stevens; Paul E Thomas; Marvin A Cuchens
Journal:  Int J Environ Res Public Health       Date:  2005-04       Impact factor: 3.390

5.  Harmine and harmaline downregulate TCDD-induced Cyp1a1 in the livers and lungs of C57BL/6 mice.

Authors:  Mohamed A M El Gendy; Ayman O S El-Kadi
Journal:  Biomed Res Int       Date:  2012-12-20       Impact factor: 3.411

6.  The effect of resveratrol and its methylthio-derivatives on the Nrf2-ARE pathway in mouse epidermis and HaCaT keratinocytes.

Authors:  Violetta Krajka-Kuźniak; Hanna Szaefer; Tomasz Stefański; Stanisław Sobiak; Michał Cichocki; Wanda Baer-Dubowska
Journal:  Cell Mol Biol Lett       Date:  2014-08-29       Impact factor: 5.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.